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Background and purpose   Hip resurfacing (HRS) procedures 
have gained increasing popularity for younger, higher-demand 
patients with degenerative hip pathologies. However, with con-
cerns regarding revision rates and possible adverse metal hyper-
sensitivity  reactions  with  metal-on-metal  articulations,  some 
authors  have  questioned  the  hypothesized  superiority  of  hip 
resurfacing  over  total  hip  arthroplasty  (THA).  In  this  meta-
analysis, we compared the clinical and radiological outcomes and 
complication rates of these 2 procedures. 
Methods   A systematic review was undertaken of all published 
(Medline,  CINAHL,  AMED,  EMBASE)  and  unpublished  or 
gray literature research databases up to January 2010. Clinical 
and radiological outcomes as well as complications of HRS were 
compared to those of THA using risk ratio, mean difference, and 
standardized  mean  difference  statistics.  Studies  were  critically 
appraised using the CASP appraisal tool.
Results   46 studies were identified from 1,124 citations. These 
included 3,799 HRSs and 3,282 THAs. On meta-analysis, func-
tional outcomes for subjects following HRS were better than or 
the same as for subjects with a THA, but there were statistically 
significantly greater incidences of heterotopic ossification, aseptic 
loosening, and revision surgery with HRS compared to THA. The 
evidence base showed a number of methodological inadequacies 
such as the limited use of power calculations and poor or absent 
blinding of both patients and assessors, possibly giving rise to 
assessor bias.
Interpretation   On the basis of the current evidence base, HRS 
may have better functional outcomes than THA, but the increased 
risks of heterotopic ossification, aseptic loosening, and revision 
surgery following HRS indicate that THA is superior in terms of 
implant survival.
 
Over the last 3 decades, the threshold for total hip arthroplasty 
(THA) has been lowered to include younger and more physi-
cally demanding patients (Abraham et al. 2006, Treacy 2006). 
However, hip arthroplasty surgery in younger patients with 
more demanding lifestyles has been reported to fail earlier 
(Tennent and Goddard 2000, Lewthwaite et al. 2008, How-
croft et al. 2008). In order to address this issue, some surgeons 
have advocated the use of metal-on-metal or ceramic bearing 
surfaces with cementless porous coated prostheses to reduce 
implant surface wear rates and bone loss in younger osteoar-
thritics (Shetty and Villar 2006). Other surgeons have advo-
cated hip resurfacing (HRS) for young patients (Harty et al. 
2005, Abraham et al. 2006, Bengs et al. 2008, Greene et al. 
2009). 
 Hip resurfacing has gained wider support over the past 
10 years with the development of more successful implants 
and improvements in manufacturing techniques and materi-
als compared to previous generations of failed HRS designs 
(Treacy 2006, Deuel et al. 2009). Hip resurfacing theoretically 
allows for greater bone stock preservation, lower wear rates, 
retention of the femoral neck, and the use of a larger bearing 
surface (McMinn and Daniel 2006, Hing et al. 2007, Heilp-
ern et al. 2008, Steffen et al. 2008, Daniel et al. 2010). Some 
authors have suggested that approximation to the native femo-
ral head-to-neck ratio therefore allows greater range of motion 
before component impingement, and improved function over 
conventional THA (Chandler et al. 1982, Alberton et al. 2002, 
Barrack 2003). Proponents of HRS have also suggested that 
if revision surgery is required, converting to a THA is easier 
than revising a THA and is theoretically similar to performing 
a primary THA, due to the greater bone preservation initially 
(Ball et al. 2007, Bengs et al. 2008). However, concerns have 
been raised recently regarding systemic exposure to cobalt 
and chromium ions, with the larger bearings used in HRS 
resulting in aseptic lymphocytic vasculitis-associated lesions 
(ALVAL); the long-term consequences of this are yet to be 
defined (Davies et al. 2005, Pandit et al. 2008, Glyn-Jones 
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have also suggested that the proposed advantages of HRS with 
respect to range of motion and functional outcomes may not 
be true compared to contemporary THA surgery (Bengs et al. 
2008, Le Duff et al. 2009, Malviya et al. 2010). In addition, 
revision of an HRS may in fact be more technically demand-
ing than that of a primary THA (Günther et al. 2008, Taylor 
et al. 2009).
Given  the  debate  about  the  efficacy  of  these  2  implant 
designs, we wanted to determine whether there is a differ-
ence in clinical and radiological outcomes between conven-
tional THA and HRS. While previous studies have narratively 
reviewed the evidence base on this topic or compared the clin-
ical outcomes of THA and HRS cohorts from separate studies 
(Wyness et al. 2004, Marker et al. 2009, Springer et al. 2009), 
there has been no formal meta-analysis comparing THA and 
HRS cohorts after a systematic review. 
Materials and methods
Search strategy
All searches were conducted on January 10, 2010. The pri-
mary search was of the databases Medline (1950 to January 
2010),  CINAHL  (1982  to  1950  to  January  2010), AMED 
(1985  to  1950  to  January  2010)  and  EMBASE  (1974  to 
1950 to January 2010). These were searched via Ovid using 
MeSH terms and the Boolean operators “hip AND (replace-
ment  OR  arthroplasty)  AND  resurfacing”.  A  secondary 
search  of  unpublished  literature  was  conducted  using  the 
databases SIGLE (System for Information on Grey Litera-
ture in Europe), the National Technical Information Service, 
the National Research Register (UK), the British Library’s 
Integrated  Catalogue,  and  Current  Controlled  Trials  using 
the same search terms as used in the primary search. Broad 
search terms were used to minimize the possibility of omit-
ting important citations from the review. Conference proceed-
ings of the British Orthopaedic Association (BOA) Annual 
Congress, the European Federation of National Associations 
of Orthopaedics and Traumatology (EFORT), and the British 
Hip Society were searched from their inception to January 
2010. The reference lists of each potentially relevant paper 
and  review  papers  were  appraised  for  relevant  papers  not 
identified  by  the  initial  search.  Finally,  the  corresponding 
authors of each paper included were contacted for citations 
not identified from the original searches.
Eligibility criteria
Using  the  results  from  the  search  strategy,  all  randomized 
controlled trials (RCTs) and non-randomized controlled trials 
(nRCTs) comparing HRS and THA implants for patients with 
hip pathology were identified and included. The search strat-
egy  was  unspecific  regarding  the  joint  prostheses  used  for 
each cohort, subject age, sex, and the rationale for surgery. 
There were no language restrictions in the searches. Animal 
studies, cadaver studies, single case reports, comments, let-
ters, editorials, protocols, guidelines, publications based on 
surgical registries, and review papers were excluded due to 
their methodological quality. 2 reviewers (TS and RN) inde-
pendently reviewed the eligibility of each citation identified, 
using the titles and abstracts based on these criteria. For each 
eligible or potentially eligible article, full text versions were 
ordered when available. 
Data extraction
Data were extracted from the included papers by 1 reviewer 
and verified by a second review using a predefined data extrac-
tion  spreadsheet.  Data  fields  extracted  included:  operative 
techniques, study sample size, cohort age at surgery, sex, indi-
cations for surgery, implants used, assessment procedures and 
outcome measures, results, and follow-up period. 
Critical appraisal
All  the  papers  included  were  independently  assessed  by  2 
reviewers  using  a  modified  CASP  assessment  tool  (CASP 
2010). This is a 17-item appraisal tool consisting of 4 sec-
tions: an assessment of study validity; an evaluation of meth-
odological quality such as subject identification, randomiza-
tion, blinding, and subject drop-out rates; an assessment of the 
presentation of results using descriptive and inferential statis-
tics with confidence intervals; and an assessment of external 
validity and generalizability to clinical practice.
Any disagreements about paper eligibility, data extraction 
results, or critical appraisal score were resolved through dis-
cussion between the independent reviewers. 
Primary outcome measure
The primary outcome measure was frequency of revision sur-
gery. 
Secondary outcome measures 
Secondary  clinical  outcome  measures  included:  incision 
length,  last  acetabular  reamer  size,  duration  of  operation, 
blood loss and frequency of blood transfusion requirement, 
length of hospital stay, pain, functional outcome and quality of 
life outcome, and hip range of motion. Radiological outcomes 
included: femoral and acetabular offset, the frequency of fem-
oral or acetabular radiolucency, leg length, cup height (mea-
sured as the distance in the vertical plane from the center of 
rotation of the acetabulum to the line drawn between the base 
of the teardrops, parallel to Hilgenreiner’s line (Loughead et 
al. 2005), and the incidence of heterotopic ossification. Com-
plications assessed included: venous thromboembolic events 
(VTEs), acetabular component malposition, trochanteric mal-
union or nonunion, nerve palsy, presence of a Trendelenburg 
sign, fracture incidence and femoral neck notch incidence, 
dislocation rate, incidence of aseptic loosening or avascular 
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and 95% confidence intervals (CIs) were calculated. When not 
enough data were available in the original report or publica-
tion, attempts were made to contact the corresponding authors. 
Finally, a funnel plot was generated to assess publication bias 
for the outcome measure most frequently reported. 
The meta-analysis was conducted by one investigator using 
REVMAN  software  (version  5.0  for Windows;  the  Nordic 
Cochrane  Center,  Copenhagen,  Denmark)  (The  Cochrane 
Collaboration, 2008).
Results
Search strategy
1,124 citations were identified from the search strategy. 46 
studies were deemed appropriate (Figure 1). The findings of 
one study appeared to be reported in 2 papers (Vendittoli et al. 
2006a, b). We therefore included all data from the publication 
which presented the largest dataset (Vendittoli et al. 2006a) 
and excluded the other publication. As Figure 2 shows, there 
was minimal publication bias evident for the primary outcome 
frequency of revision surgery.
Cohort characteristics
From the 46 citations, 28 prospective observational studies, 
8 retrospective studies, and 10 RCTs were identified (Tables 
1–3). 3,799 HRSs in 3,279 patients were compared to 3,282 
THAs in 2,910 patients. Mean age in the HRS group was 51 
(SD 7) years, while mean age in the THA group was 54 (SD 
8) years. There was a trend of an older average age of sub-
jects in the THA groups compared to HRS groups (see Tables 
1–3). In the HRS cohorts, 1,578 males were compared to 806 
females; 7 papers did not state the sex of the patients. In the 
THA cohorts, 1,176 males were compared to 959 females, 
and 8 papers did not state the sex of the patients. Mean fol-
low-up period was 25 (SD 27) months, as stated in 23 studies. 
This ranged from immediately postoperatively (Vendittoli et 
al. 2006a, Brennan et al. 2009) to 82 months (Gustilo et al. 
1983). 
A variety of different HRS and THA prostheses were used in 
the studies reviewed. The most commonly used HRS system 
was the Birmingham Hip Resurfacing (Smith and Nephew, 
Warwick, UK), which was used in 15 papers, while the Durom 
Additional records identiﬁed through 
other sources (n = 0) 
Records after duplicates were removed (n = 685) 
Studies included in the qualitative synthesis (n = 46) 
Records screened (n = 685) 
Full-text articles excluded (n = 26) 
– population unclear (n=1) 
– repeated publication (n=2) 
– cadaveric/sawbone study (n=3) 
– outcomes of interest not  
presented (n=10) 
– review/editorial papers (n=10) 
Full-text articles assessed for 
eligibility (n = 72) 
Records excluded (n = 613) 
Records identiﬁed through database 
searching (n = 1124) 
Studies included in the meta-analysis (n = 46)
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Figure 1. PRISMA flow chart.
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Figure 2. Funnel plot showing limited evidence of publication bias for 
the frequency of revision surgery.
Review protocol
A review protocol was not published before 
commencing the study.
Statistics
A  meta-analysis  was  undertaken  using  the 
results  from  the  agreed  extraction  table. 
Meta-analysis  was  only  conducted  where 
there was no observed evidence of a substan-
tial difference in study populations, interven-
tions, or outcome measures on review of the 
extraction table. We assessed statistical het-
erogeneity with Chi2 and I2 statistical tests. 
Where  statistical  heterogeneity  (measured 
using I2) was less than 20%, a fixed effects 
model was used. For outcomes above 20%, 
a random effects model was used (Higgins 
et  al.  2003). The  Mantel-Haenszel  method 
was used to calculate mean pooled difference 
(MD) for continuous data, and pooled risk 
ratios  (RR)  for  dichotomous  data  (Mantel 
and  Haenszel  1959). A  probability  of  p  < 
0.05 was regarded as statistically significant, Acta Orthopaedica 2010; 81 (6): 684–695  687
hip resurfacing system (Zimmer, Warsaw, IN) was used in 8 
papers and the Conserve Plus (Wright Medical Technology, 
Arlington, TN) was used in 6 (Table 4). The THA systems 
used varied considerably (Table 5). 
Meta-analysis
Clinical outcomes. The results of the meta-analysis indicated 
that there was a statistically significant difference between 
HRS and THA for a number of clinical outcomes. Function-
ally, there was a significantly higher WOMAC score (Bellamy 
et al. 1988) for patients who underwent THA at final follow-
up, indicating poorer functional ability (MD = –2.4, CI: –3.9, 
–0.9; p = 0.001), and better range of motion component of 
the Harris hip score (HHS) (Harris 1969) (MD = –0.05, CI: 
–0.1, –0.03; p < 0.001) and overall HHS (MD = 2.5, CI: 1.2, 
3.8; p = 0.001) in the HRS cohorts than in the THA cohorts. 
Significance from CI indicated that more patients who under-
went THA had greater difficulty in undertaking a step test task 
than those who had HRS (RR = 0.3, CI: 0.1, 0.6; p < 0.0014). 
However,  there  was  no  statistically  significant  difference 
between THA and HRS cohorts regarding Merle d’Aubigne 
index (Merle d’Aubigné and Postel 1954), UCLA (Amstutz 
et al. 1984), Oxford hip score (Dawson et al. 1996), or hop 
test  results  (p  >  0.05)  (Table  6),  although  these  outcomes 
were assessed with a smaller number of patients than were the 
WOMAC and HHS assessments. 
There was a difference regarding Short Form-12 (SF-12) 
physical component scores (Ware et al. 1996) (MD = 3.5, CI: 
0.6, 6.5; p = 0.02), but there was no statistically significant 
difference between prosthesis groups for SF-12 mental com-
ponent scores (Ware et al. 1996) and EQ-5D scores (Brooks 
1996) (p > 0.05). However, both outcomes had a degree of 
statistical heterogeneity (Table 6). 
There was no statistically significant difference regarding 
mean incision length, pain scores, presence of groin or thigh 
pain,  and  patient  satisfaction  outcomes  between  HRS  and 
THA cohorts at final follow-up (p > 0.05). Similarly, there was 
no significant difference between prostheses regarding range 
of motion of the hip (p > 0.05; Table 6). 
While the results indicated that there was a greater require-
ment for blood transfusion following THA (RR = 0.4, CI: 0.2, 
0.6; p < 0.001), the difference seen with longer operative dura-
tion in HRS procedures (MD = 13.6, CI: 7.5, 19.8; p < 0.001), 
greater estimated blood loss with THA (MD = –152.8, CI: 
–305.0, –0.5; p < 0.05), and longer hospital stay with THA 
(MD = –1.4, CI –2.3, –0.6; p = 0.002) should also be viewed 
with caution, based on the high levels of statistical heteroge-
neity  reported  (Table  6).  Furthermore,  while  the  outcomes 
Table 1. Demographic characteristics of randomized controlled trials
Paper  Hips  Patients  Mean age  Gender (M/F)  Follow-up period
  HRS  THA  HRS  THA  HRS  THA  HRS  THA  (months)
Garbuz et al. (2010)   48  56  48  56  52  52  43/5  50/6  Min. 12
Girard et al. (2008)  69  76  69  76  50  50  38/31  48/28  21
Girard et al.(2006)  49  55  49  55  47  48  31/18  34/21  N/S
Howie et al. (2005)  11  13  11  13  46  50    6/5    9/4  24
Lavigne et al. (2009)  24  24  24  24  50  50  14/10    5/9  14
Lavigne et al. (2008)  81  71  81  71  48  50  53/28  51/20  27
Rama et al. (2009)  103  97  103  97  50  50  65/38  66/31  12
Vendittoli et al. (2006)   107  103  107  103  49   51   67/40  70/33  Intra-op.
Vendittoli et al. (2010a)  64  53  64  53  49  51  42/22  33/20  24
Vendittoli et al. (2010b)  109  100  109  100  49  51  69/40  68/32  24
Intra-op.: intra-operatively; N/S: not stated; THA: total hip replacement.
Table 2. Demographic characteristics of retrospective studies
Paper  Hips  Patients  Mean age  Gender (M/F)  Follow-up period
  HRS  THA  HRS  THA  HRS  THA  HRS  THA  (months)
Brennan et al. (2009)  31  31  31  31  59  61    24/7    13/18  Intra-op.
Kim et al. (1987)   106  98  N/S  N/S  27  28    65/41    56/42  60
Meldrum et al. (2008)   141  125  118  103  47  47    80/32    58/45  Min. 14
Mont et al. (2009)  54  54  54  54  55  55    36/18    36/18  39
Naal et al. (2009)  362  181  N/S  N/S  N/S  N/S  250/112  125/56  Intra-op.
Pollard et al. (2006)  54  51  54  53  50  50    40/11    40/13  Min. 71
Swank and Alkire (2009) 128  105  128  105  51  N/S  100/28    N/S  24
Vail et al. (2006)  57  93  52  84  47  57    41/11    23/61  35
Intra-op.: intra-operatively; N/S: not stated; THA: total hip replacement.688  Acta Orthopaedica 2010; 81 (6): 684–695
were statistically significantly different, there were no clini-
cally significant differences between the 2 prostheses.
Radiological outcomes. The radiological outcomes assessed 
showed a higher presence of heterotopic ossification (RR = 
1.6, CI: 1.2, 2.1; p = 0.006) in HRS cases than in THA cases. 
There was no statistically significant difference between the 2 
prostheses regarding acetabular or femoral offset, leg length, 
cup height, or for the presence of specific acetabular or femo-
ral radiolucency (p > 0.05) (Tables 7 and 8).
Complications. The primary outcome under investigation 
was the frequency of revision surgery. The risk of revision sur-
gery following HRS compared to conventional THA almost 
doubled (RR = 1.7, CI: 1.2, 2.5; p = 0.003) (Figure 3). There 
was also a 3 times greater risk of aseptic loosening in HRS 
patients than in THR patients (RR = 3.1; 95% CI: 1.1, 8.5; p 
= 0.03) (Figure 4). These 2 outcomes also showed statistical 
heterogeneity. There was a reduced incidence of dislocation 
(RR = 0.2, CI: 0.1, 0.5; p < 0.001) following HRS compared 
to THA, with no issues of statistical heterogeneity (Table 9).
There was no statistically significant difference regarding 
the incidence of postoperative fracture, VTE or pulmonary 
embolism (PE), joint infection, acetabular component mal-
Table 3. Demographic characteristics of observational studies
Paper  Hips  Patients  Mean age  Gender (M/F)  Follow-up period
  HRS  THA  HRS  THA  HRS  THA  HRS  THA  (months)
Ahmad et al. (2009)   28  28  28  28  54  61    14/14    10/18  N/S
Amstitz et al. (1984)  100  100  91  86  58  66    60/31    35/51  Min. 22
Chirodian et al. (2004)  44  50  44  50  48  52    28/16    22/28  12
Fowble et al. (2009)  50  44  50  35  46  55    31/19    18/26  Min. 24
Gore et al. (1985)  27  29  27  29  55  62    27    29  N/S
Gustilo et al. (1983)  75  91  67  75  75  49    N/S     N/S  82
Hall et al. (2009)  33  99  33  99  54  55    27/6    81/18  6
Hayaishi et al. (2007)  10  16  10  16  N/S  N/S    N/S     N/S  12
Kishida et al.(2004)  13  13  13  12  58  58    7/6      3/9  24
Langton et al. (2010) BHR  155  87  155  87  51  67    88/67    34/53  Min. 8
Langton et al. (2010) ASR  418  87  418  87  56  67  234/184    34/53  Min. 8
Le Duff et al. (2009)  35  35  35  35  53  53    24/11    24/11  88
Leonard et al. (2007)  40  85  40  85  N/S  N/S    N/S    N/S  N/S
Lilikakis et al. (2005)  35  41  33  40  53   65     20/13    14/26  0.3
Lingard et al. (2009)  132  214  132  214  49  67    90/42    90/146  12
Loughead et al. (2005)  28  26  28  26  50  62    N/S    N/S  N/S
Mont et al. (2007)  15  15  15  15  51  58    10/5      9/6  12
Mont et al. (2001)  30  30  30  30  34  35    18/12    18/12  84
Moroni et al. (2008)  25  27  20  26  49  48    10/10    12/14  Min. 24 
Patel et al. (2009)  12  12  12  12  56  58      9/3      9/3  6
Pattyn and De Smet (2008)  250  190  250  190  50  45    N/S     N/S  Min. 36
Ritter and Gioe (1986)  50  50  50  50  62  62    27/23    27/23  Min. 60
Robb et al. (2009)  30  30  30  30  55  67    18/12    12/18  N/S
Silva et al. (2004)  50  40  50  32  47  54    31/19    12/20  N/S
Stulberg et al. (2009)  337  266  337  266  50  53  228/109  165/101  Min. 24
Wagner and Wagner (1996)  35  70  35  70  36  50      4/31    19/51  Min. 34
Witzleb et al. (2006)  111  88  111  74  51  54      N/C    N/C  N/C
Zywiel et al. (2009)  33  33  33  33  53  53    23/10    23/10  Min. 42
Table 4. Summary of the hip resurfacing prostheses used in the studies included in this 
systematic review
Birmingham Hip Resurfacing system (Smith and Nephew, Warwick, UK)  15
Durom hybrid resurfacing system (Zimmer, Warsaw, IN)   8
Conserve Plus (Wright Medical Technology, Arlington, TN)   6
Cormet MoM (Corin, Cirencester, UK)   4
Tharies prosthesis   2
Indiana Conservative SR   2
McMinn acetabular component and mini stemmed McMinn femoral resurfacing 
  component (Corin Medical Ltd., Gloucestershire, UK)   1
Articular Surface Replacement (DePuy International Ltd., Leeds, UK)   1
Stemless resurfacing system (DePuy, Warsaw, IND)   1
MoM Metasul articulating surfaces prostheses   1
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positioning, trochanteric malunion, peroneal or sciatic nerve 
palsy,  trochanteric  bursitis,  clinical  leg  length  discrepancy, 
squeaking, positive Trendelenburg sign, or mortality between 
HRS and THA cohorts (p > 0.05) (Table 9). There was no 
statistically significant difference between the frequency of 
adverse reaction to metal debris between HRS and THA. 
Critical appraisal outcomes. The CASP review showed that 
while 44 papers provided a clearly focused question, only 10 
were RCTs (Table 10). All studies were undertaken at inde-
pendent centers, with none conducted in implant inception 
centers. Of these studies, 9 clearly described the method of 
randomization, while in 25 studies the authors were able to 
demonstrate that their groups were comparable at baseline. 
The study population was clearly defined in 33 studies. Asses-
sor blinding was used in 4 studies, while patients were blinded 
as to the type of prosthesis in only 2. In 16 studies, the results 
were analyzed by intention-to-treat methods or it was stated 
that all who started the study in the respective groups were 
analyzed according to the initial allocation. A power calcu-
lation was used to justify the study sample sizes in 14 stud-
ies. 35 studies used inferential statistics to compare outcomes 
between the groups, but the precision of the results was pre-
sented using confidence intervals in only 5. In 35 studies, the 
authors interpreted their results appropriately and associated 
their findings to the previous evidence base.
Discussion
Our findings indicate that while functional outcomes follow-
ing HRS were better or the same as those following THA, 
there is a higher risk of heterotopic ossification, aseptic loos-
ening, and subsequent early revision surgery for patients who 
undergo HRS rather than THA. Accordingly, THA appears to 
be superior to HRS on the basis of the current evidence base. 
However,  the  evidence  base  presented—with  a  number  of 
methodological inadequacies such as the limited use of power 
calculations and poor or absent blinding of both patients and 
assessors—can give rise to assessor bias. The evidence base 
was also guilty of poorly documenting methods of recruitment, 
Table 5. Summary of the total hip arthroplasty prostheses used in the studies included in this systematic review
Implant  Frequency
Metasul femoral head and M/L Taper stem (Zimmer, Warsaw, IN)   3
THR (Stryker-Howmedica-Osteonoics) Trident cup and Accolade femoral component (ceramic or cobalt chrome heads on PE liner   2
Trapezoidal-28 THA   2
Cemented CPS stem (Plus Orthopedics, Swindon, UK) and EPF uncemented acetabular component (Plus Orthopedics)  1
Trident Acetabular component and uncemented THA  1
Ultima cemented femoral stem and Duraloc acetabular component (DePuy, Leeds, UK)   1
Uncemented Birmingham Hip Resurfacing acetabular cup and Freeman stem (Finsbury, Surry, UK)   1
Exeter stem and PE acetabular component (Howmedica, London, UK)   1
Axcel THA (Axcel, Cremascoli, Milan, Italy)   1
Summit and Pinnacle uncemented stem (DePuy Orthopaedics Inc, Warsaw, IN) with Marathon PE acetabular 
   (DePuy Orthopaedics Inc.) or Metal acetabulum (Ultamet; DePuy Orthopaedics Inc.)   1
CLS Spotorno grit-blasted titanium uncemented femoral stem and Metasul femoral head (Zimmer, Winterthur, Switerland)   1
Charnley and T-28 prostheses   1
ASR with Corail or SROM stem (DePuy International Ltd., Leeds, UK)   1
CLS femoral stem (Zimmer, Warsaw, IN) and Durom acetabular component   1
Stemmed THR   1
Exeter stem and conteoporary cup (Stryker, Howmedica, Newbury, UK) or Corail stem and ASR cup (DePuy International Ltd., UK)   1
Uncemented Trident Acetabular System and Accolade Femoral Hip System (Stryker-Howmedica-Osteonics, Allendale, NJ)   1
Exeter stem (Stryker, Howmedica, Newbury, UK) and ABG II (Stryker, Howmedica) or Trilogy acetabular component (Zimmer, Warsaw, IN)  1
Stemmed THA   1
PCA stem and System 12 acetabular cup (Stryker-Howmedica-Osteonics, Allendale, NJ)   1
Metasul MoM THR (Sulzer Orthopedics Ltd., Winterthur, Switzerland)   1
Allofit cup (Zimmer, Warsaw, IN)   1
Hybrid THA of Spectron cemented femoral component (Smith and Nephew Orthopaedics, UK), with Triology uncemented acetabular 
   component (Zimmer Ltd., UK)  1
Ancafit CoC THA (Wright Medical, Arlington, TN)   1
Hybrid THA with PE liner  1
Metasul acetabular liner and femoral head (Zimmer, Warsaw, IN)   1
Exeter stem (Stryker, UK) with polyethylene Opera acetabular cup (Smith and Nephew, UK). Cemented procedure   1
CoC Stryker ABC System (Stryker Orthopaedics, Mahwah, NJ)   1
Uncemented - G2 femoral stem and Duraloc or Pinnacle cup (DePuy Orthopedics, Warsaw, IN) for metal on PE implant  1
CLS Spotorno (Zimmer, Warsaw, IN) Allofit acetabular shell (Zimmer), Metasul acetabular PE insert. 28-mm femoral head. Uncemented   1
MoM Cone prosthesis and CLS stem (Protek AG, Berne, Switzerland)   1
MoM THA (Metasul; Sulzer Orthopedics Ltd., Switzerland)   1
Not Stated   5
CoC: ceramic-on-ceramic; MoM: metal-on-metal; PE: polyethylene; THR: total hip replacement.690  Acta Orthopaedica 2010; 81 (6): 684–695
thus permitting allocation or recruitment bias. 
Regarding these factors, the current evidence 
base—while being substantial in size—may 
be questioned with respect to its quality.
Some  results  obtained  from  the  meta-
analysis  may  have  been  predictable,  due  to 
inherent  differences  between  the  2  designs. 
For example, the larger head size of the HRS 
provides greater stability (thus reducing the 
risk of dislocation), the removal of the femo-
ral head in THA reduces the risk of avascular 
necrosis of the femoral head, and the need to 
site the femoral component would predispose 
the HRS system to show a greater incidence 
of  femoral  neck  notching,  compared  to  the 
THA (Table 9). It is noteworthy that Shimmin 
and Back (2005) suggested that most failures 
in HRS procedures are due to fractures of the 
femoral neck, with an approximate incidence 
of  2%. While  the  exact  mechanism  of  this 
complication remains unknown, it has been 
speculated  that  such  fractures  occur  due  to 
notching of the femoral neck during surgery, 
varus placement of the femoral component, 
or poor bone quality in the neck (Cossey et 
al. 2005, Shimmin and Back 2005, Deuel et 
al. 2009). Accordingly, whether the frequency 
of these complications is then a function of 
surgical  technique  or  the  design  of  specific 
prostheses, or whether anatomical variance is 
a further issue that may provide variation in 
the incidence of such complications, remains 
unknown.
There is growing evidence of adverse reac-
tions occurring with metal-on-metal articula-
tions (Bengs et al. 2008). It remains unclear 
whether  this  is  due  to  implant  design,  to 
bearing congruence associated with malposi-
tioning of implants, or to patient response to 
metal ions. Some studies have suggested that 
HRS can lead to higher levels of chromium 
and  cobalt  levels  than  metal-on-metal THA 
at final follow-up (Hart et al. 2006, Witzleb 
et al. 2006, Moroni et al. 2008, Daniel et al. 
2010, Langdon et al. 2010). If future studies 
substantiate these findings, greater consider-
ation may be required regarding the appropri-
ateness of metal-on-metal implants in the long 
term compared to alternative bearings such as 
ceramic-on-ceramic or metal-on-polyethylene 
bearings. 
Our  study  shows  that  the  frequency  of 
revision surgery was nearly twice as high in 
patients who underwent HRS as in those who 
Table 6. Clinical outcomes after meta-analysis
Outcome  Mean difference  p-value  Heterogeneity
  (95% CI)    I2 (%)  Chi2
Last reaming required     0.78  (-0.22 – 1.78)  0.1  70  0.07
Mean incision length    6.42  (-0.49 – 15.33)  0.2  94  < 0.001
Duration of operation  13.63  (7.48 – 19.79)  < 0.001  74  0.004
Estimated blood loss     -152  (-305 – -0.5)  < 0.05  78  0.01
Length of hospital stay    -1.44  (-2.34 – -0.55)  0.002  93  < 0.001
Merle d’Aubigne index   -0.08  (-0.23 – 0.07)  0.3  0  0.61
UCLA     0.72  (-0.27 – 1.71)  0.2  90  < 0.001
Short Form-12 (mental)     1.90  (-8.25 – 4.04)  0.1  0  0.68
Short Form-12 (physical)    3.54  (0.60 – 6.48)  0.02  41  0.18
EQ-5D     0.03  (-0.05 – 0.11)  0.5  N/E  N/E
Patient satisfaction  N/E  N/E  N/E  N/E
Patient satisfaction 
   (satisfied/very satisfied)     1.13  (0.94 – 1.35)  0.2  87  0.07
HHS     2.51  (1.24 – 3.77)  < 0.001  28  0.25
HHS (Function)   N/E  N/E  N/E  N/E
WOMAC    -2.41  (-3.88 – -0.94)  0.001  0  0.77
Oxford hip score    -4.13  (-7.41 – -0.86)  0.6  34  0.22
HHS (ROM)    -0.05  (-0.07 – -0.03)  < 0.001  N/E  N/E
Flexion ROM   -0.23  (-3.78 – 3.31)  0.9  0  0.58
Abduction ROM    -0.31  (-2.16 – 1.55)  0.8  0  0.51
Adduction ROM     3.00  (-0.92 – 6.92)  0.1  N/E  N/E
Internal rotation ROM    2.00  (-4.27 – 8.27)  0.5  N/E  N/E
External rotation ROM    1.00  (-3.51 – 5.51)  0.7  N/E  N/E
Total rotation ROM   -3.83  (-17.50 – 9.85)  1.0  79  0.03
Hop test    0.94  (0.16 – 7.53)  0.9  87  0.005
Step test    0.26  (0.12 – 0.55)  < 0.001  0  0.85
Pain a    -0.14  (-0.35 – 0.06)  0.2  0  0.36
Presence of groin pain     0.30  (0.59 – 5.27)  0.2  39  0.20
Presence of thigh pain     0.48  (0.09 – 2.55)  0.4  N/E  N/E
Frequency of blood 
   transfusion requirement     0.37  (0.23 – 0.61)  < 0.001  0  0.97
a standardized mean difference.
HHS: Harris hip score; N/E: not estimable; ROM: range of motion.
Table 8. Radiology outcomes (dichotomous) following meta-analysis
Outcome  Risk ratio  p-value  Heterogeneity
  (95% CI)    I2 (%)  Chi2
Heterotopic ossification   1.62  (1.23 – 2.14)  < 0.001  16  0.3
Acetabular radiolucency present  1.27  (0.18 – 8.78)  0.8  60  0.1
Femoral radiolucency present   0.72  (0.03 – 19.47)  0.8  82  0.004
Table 7. Radiological outcomes following meta-analysis
Outcome  Mean difference  p-value  Heterogeneity
  (95% CI)    I2 (%)  Chi2
Femoral offset   -15.49  (-48.31 – 17.33)  0.4  100  < 0.001
Acetabular cup offset      2.20  (-0.95 – 5.35)  0.2  N/E     N/E
Leg length a     -0.62 (-1.48 – 0.24)  0.2  93  < 0.001
Cup height     N/E  N/E  N/E     N/E
a standardized mean difference
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underwent THA. Some authors have suggested that this may 
be due to the design of the prostheses. Bengs et al (2008) 
suggested that this may be caused by, or at least contributed 
to by a relatively short arc of motion and a predominance 
of  neck-on-cup  impingement.  However,  HRS  is  a  techni-
cally demanding procedure. As with unicompartmental knee 
replacement, surgeons who are unfamiliar with the procedure, 
or those undertaking a minimally invasive approach, may have 
a greater potential for technical errors, which may lead to a 
greater requirement for revision surgery compared to the more 
commonly undertaken conventional THA (Siebel et al. 2006, 
Morlock et al. 2008a). Some authors have suggested that there 
is a considerable learning curve to HRS procedures (Shim-
min et al. 2005). Notably, the cup inclination angle may be 
particularly important regarding optimal positioning to reduce 
impingement, which could relate to implant failure or asym-
metrical bearing wear (Siebel et al. 2006, De Haan et al. 2008, 
Morlock et al. 2008b).
The design of the HRS preserves femoral bone stock (Craw-
ford et al. 2005, Su et al. 2010). While in this review we found 
no significant difference in bone removal between the size of 
the last reamer required to prepare the acetabulum (reiterated 
Figure 3. Forest plot to illustrate the difference in frequency of revision surgery between hip resurfacing and total hip replacement. 
Figure 4. Forest plot to illustrate the difference in frequency of aseptic loosening between hip resurfacing and total hip replacement. 692  Acta Orthopaedica 2010; 81 (6): 684–695
in the clinical experiences of Muirhead-Allwood et al. (2006), 
some authors have reported that substantially greater acetabu-
lar bone removal occurs with HRS than in conventional THA 
(Crawford et al. 2005, Loughead et al. 2006, Naal et al. 2009). 
In this instance, if acetabular failure were to occur, this would 
be more challenging to revise in a resurfacing implant com-
pared to a conventional implant, as indicated in recent case 
series (Cuckler 2006, Sandiford et al. 2008, Taylor et al. 2009, 
Lachiewicz 2009). Continuing research is required to assess 
the long-term outcomes of revision of HRS. 
Bone mineral density (BMD) was assessed by Kishida et al.   
(2004) and Hayaushi et al. (2007). They concluded that post-
operative BMD was greater in the proximal femur in patients 
treated with HRS than in those treated with conventional THA, 
suggesting that the transfer of load to the proximal femur was 
more physiological after HRS. However, this may be depen-
dent on the design of the conventional THA used, where the 
stem would transfer the load of the femoral neck more physi-
ologically rather than causing simultaneous stress shielding 
(Kärrholm et al. 2002, Albanese et al. 2006). Watanbe et al. 
required to evaluate these assumptions further.
No studies assessing the cost effectiveness of HRS com-
pared to THA surgery were identified. This is a major issue, 
given that this study has indicated that HRS is a surgical option 
for patients who are of working age (mean age 51 years), and 
there may be further costs associated with a greater incidence 
of revision surgery compared to THA. McKenzie et al. (2003) 
assessed the economic effects of both younger and physically 
active elderly patients with HRS in relation to THA patients. 
They reported that while a THA was more cost effective, this 
difference was minimal between the groups. They concluded 
that there was not enough long-term data to answer this ques-
tion fully. Further studies have been proposed to address this 
research question (Achten et al. 2010). Following this and 
similar studies, it will then be possible to determine the most 
clinical and cost-effective means of managing younger and 
physically active patients. 
Our study had 3 limitations. Firstly, the objective was to 
assess whether there was a difference in clinical outcomes 
between patients who underwent HRS and those who under-
went THA. Accordingly, we have therefore not attempted to 
assess whether there is a difference in outcomes between spe-
cific THA or HRS prostheses in the meta-analysis. Secondly, 
while our study indicated that there may be some small dif-
ferences in functional outcomes between these 2 designs, it 
remains unclear whether this is attributable to differences in 
functional kinematics, as motion analysis studies were also 
not assessed in this review. Furthermore, it remains unclear 
whether the small difference in age between the 2 cohorts was 
an important confounding variable between the 2 prostheses. 
Finally, recent studies have begun to investigate reasons for 
HRS failure (Nunley et al. 2009, Yue et al. 2009). These have 
Table 9. Complication outcomes following meta-analysis
Outcome  Risk ratio  p-value  Heterogeneity
  (95% CI)    I2 (%)  Chi2
Femoral neck notching   9.2  (2.4–34.7)  0.001  0  0.9
Avascular necrosis   6.8  (1.7–27.6)  0.01  0  0.6
Aseptic loosening   3.1  (1.1–8.5)  0.03  52  0.03
Revision surgery   1.7  (1.2–2.5)  0.003  30  0.1
Positive Trendelenburg sign   1.7  (0.4–7.0)  0.5  0  0.8
Acetabular malposition   1.5  (0.7–3.1)  0.3  0  0.8
Peroneal nerve plasy   1.2  (0.3–5.6)  0.8  0  0.7
Mortality   1.1  (0.1–17.8)  0.9  62  0.1
Clinical leg length discrepancy  1.1  (0.2–7.4)  0.9  29  0.2
Fracture   0.9  (0.5–1.7)  0.8  0  0.7
Squeaking   0.9  (0.04–18.5)  0.9  51  0.2
Trochanteric bursitis  0.9  (0.1–8.1)  0.9  46  0.2
DVT-PE   0.8  (0.3–2.0)  0.6  0  0.7
Trochanteric malunion   0.8  (0.2–2.6)  0.7  0  0.6
Sciatic nerve palsy   0.7  (0.2–3.1)  0.6  0  0.6
Joint infection   0.5  (0.2–2.8)  0.1  0  0.8
Adverse reaction to metal 
  debris failure   0.2  (0.02–2.5)  0.2  62  0.1
Dislocation  0.2  (0.1–0.5)  < 0.001  0  0.9
DVT-PE: Deep vein thrombosis and pulmonary embolism
Table 10. Summary of the CASP 
appraisal results
CASP score  Frequency
(maximum 17)
  0–3   1
  4–7   16
  8–11  23
12–15  5
16–17  0
(2000)  conducted  a  finite-element  analysis 
study of HRS. They reported stress shield-
ing in the anterosuperior region of the fem-
oral neck beneath the prosthesis and stress 
concentrations around the short stem in the 
inferior cross section of the femoral neck. 
These authors suggested that these changes 
may contribute to fractures of the femoral 
neck and long-term aseptic loosening, which 
may support the higher incidence of loosen-
ing found in this meta-analysis. Kishida et al 
(2004) suggested that such fractures are early 
complications and that atrophy of the femo-
ral neck from stress shielding would occur as 
a later complication. This is contrary to their 
findings of BMD presentation in the proxi-
mal femur, which reported the distribution 
of stress after a hip resurfacing as relatively 
normal (Kishida et al. 2004). Since there was 
not enough data to allow a meta-analysis of 
different  BMD  values  between  HRS  and 
THA,  further  studies  assessing  BMD  are Acta Orthopaedica 2010; 81 (6): 684–695  693
indicated that age and sex appear to be important prognos-
tic variables (Nunley et al. 2009, Yue et al. 2009, McBryde et 
al, 2010). It was not possible to perform subgroup analysis to 
determine whether there was a difference between THR and 
HRS in this review. Further study is therefore recommended 
to assess these variables.
Conclusions
In summary, our findings indicate that functional outcomes 
following HRS are better or the same as for THA, but that 
there is an increased risk of heterotopic ossification and asep-
tic loosening after HRS, and the revision rate with HRS is 
twice that with THA. THA would therefore appear to be supe-
rior to HRS.
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